Cargando…

Association of the ward pharmacy service with active implementation of therapeutic drug monitoring for vancomycin and teicoplanin—an epidemiological surveillance study using Japanese large health insurance claims database

BACKGROUND: Ward pharmacists are required for the active implementation of therapeutic drug monitoring (TDM). This epidemiological study verified whether Japanese ward pharmacists contribute to improving the TDM implementation proportions of anti-methicillin-resistant Staphylococcus aureus (MRSA) ag...

Descripción completa

Detalles Bibliográficos
Autores principales: Imai, Shungo, Momo, Kenji, Kashiwagi, Hitoshi, Miyai, Takayuki, Sugawara, Mitsuru, Takekuma, Yoh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7436959/
https://www.ncbi.nlm.nih.gov/pubmed/32832095
http://dx.doi.org/10.1186/s40780-020-00174-8
_version_ 1783572565406515200
author Imai, Shungo
Momo, Kenji
Kashiwagi, Hitoshi
Miyai, Takayuki
Sugawara, Mitsuru
Takekuma, Yoh
author_facet Imai, Shungo
Momo, Kenji
Kashiwagi, Hitoshi
Miyai, Takayuki
Sugawara, Mitsuru
Takekuma, Yoh
author_sort Imai, Shungo
collection PubMed
description BACKGROUND: Ward pharmacists are required for the active implementation of therapeutic drug monitoring (TDM). This epidemiological study verified whether Japanese ward pharmacists contribute to improving the TDM implementation proportions of anti-methicillin-resistant Staphylococcus aureus (MRSA) agents using the large health insurance claims database. METHODS: The patients who received intravenous anti-MRSA agents from April 2012 to March 2017 were enrolled. We defined ward pharmacy service as the “drug management and guidance fee” and/or “inpatient pharmaceutical services premium”. In addition, implementation of TDM was identified by “the specific drug treatment management fee”. We compared the proportions of TDM implementation for vancomycin (VCM), teicoplanin (TEIC), and arbekacin (ABK) in the ward and non-ward pharmacy service groups. To avoid confounding, the propensity score method was employed. Moreover, the clinical variables affecting TDM implementation in each anti-MRSA agent were analyzed by using a multiple logistic regression model. RESULTS: The following number of patients were included in the study: VCM (n = 2138), TEIC (n = 596), and ABK (n = 142). After propensity score matching, the proportions of TDM implementation for VCM and TEIC were higher in the ward pharmacy service group than in the non-ward pharmacy service group (VCM: 69.2% vs 60.3%, TEIC: 51.4% vs 34.7%), while no significant difference was observed for ABK (21.2% vs 23.1%). As independent clinical variables affecting TDM implementation for VCM and TEIC, several clinical variables, including ward pharmacy services, were extracted. In contrast, no clinical variables were extracted for ABK. CONCLUSIONS: We found that the ward pharmacy service is associated with the active implementation of TDM for anti-MRSA agents, such as VCM and TEIC.
format Online
Article
Text
id pubmed-7436959
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-74369592020-08-20 Association of the ward pharmacy service with active implementation of therapeutic drug monitoring for vancomycin and teicoplanin—an epidemiological surveillance study using Japanese large health insurance claims database Imai, Shungo Momo, Kenji Kashiwagi, Hitoshi Miyai, Takayuki Sugawara, Mitsuru Takekuma, Yoh J Pharm Health Care Sci Research Article BACKGROUND: Ward pharmacists are required for the active implementation of therapeutic drug monitoring (TDM). This epidemiological study verified whether Japanese ward pharmacists contribute to improving the TDM implementation proportions of anti-methicillin-resistant Staphylococcus aureus (MRSA) agents using the large health insurance claims database. METHODS: The patients who received intravenous anti-MRSA agents from April 2012 to March 2017 were enrolled. We defined ward pharmacy service as the “drug management and guidance fee” and/or “inpatient pharmaceutical services premium”. In addition, implementation of TDM was identified by “the specific drug treatment management fee”. We compared the proportions of TDM implementation for vancomycin (VCM), teicoplanin (TEIC), and arbekacin (ABK) in the ward and non-ward pharmacy service groups. To avoid confounding, the propensity score method was employed. Moreover, the clinical variables affecting TDM implementation in each anti-MRSA agent were analyzed by using a multiple logistic regression model. RESULTS: The following number of patients were included in the study: VCM (n = 2138), TEIC (n = 596), and ABK (n = 142). After propensity score matching, the proportions of TDM implementation for VCM and TEIC were higher in the ward pharmacy service group than in the non-ward pharmacy service group (VCM: 69.2% vs 60.3%, TEIC: 51.4% vs 34.7%), while no significant difference was observed for ABK (21.2% vs 23.1%). As independent clinical variables affecting TDM implementation for VCM and TEIC, several clinical variables, including ward pharmacy services, were extracted. In contrast, no clinical variables were extracted for ABK. CONCLUSIONS: We found that the ward pharmacy service is associated with the active implementation of TDM for anti-MRSA agents, such as VCM and TEIC. BioMed Central 2020-08-18 /pmc/articles/PMC7436959/ /pubmed/32832095 http://dx.doi.org/10.1186/s40780-020-00174-8 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Imai, Shungo
Momo, Kenji
Kashiwagi, Hitoshi
Miyai, Takayuki
Sugawara, Mitsuru
Takekuma, Yoh
Association of the ward pharmacy service with active implementation of therapeutic drug monitoring for vancomycin and teicoplanin—an epidemiological surveillance study using Japanese large health insurance claims database
title Association of the ward pharmacy service with active implementation of therapeutic drug monitoring for vancomycin and teicoplanin—an epidemiological surveillance study using Japanese large health insurance claims database
title_full Association of the ward pharmacy service with active implementation of therapeutic drug monitoring for vancomycin and teicoplanin—an epidemiological surveillance study using Japanese large health insurance claims database
title_fullStr Association of the ward pharmacy service with active implementation of therapeutic drug monitoring for vancomycin and teicoplanin—an epidemiological surveillance study using Japanese large health insurance claims database
title_full_unstemmed Association of the ward pharmacy service with active implementation of therapeutic drug monitoring for vancomycin and teicoplanin—an epidemiological surveillance study using Japanese large health insurance claims database
title_short Association of the ward pharmacy service with active implementation of therapeutic drug monitoring for vancomycin and teicoplanin—an epidemiological surveillance study using Japanese large health insurance claims database
title_sort association of the ward pharmacy service with active implementation of therapeutic drug monitoring for vancomycin and teicoplanin—an epidemiological surveillance study using japanese large health insurance claims database
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7436959/
https://www.ncbi.nlm.nih.gov/pubmed/32832095
http://dx.doi.org/10.1186/s40780-020-00174-8
work_keys_str_mv AT imaishungo associationofthewardpharmacyservicewithactiveimplementationoftherapeuticdrugmonitoringforvancomycinandteicoplaninanepidemiologicalsurveillancestudyusingjapaneselargehealthinsuranceclaimsdatabase
AT momokenji associationofthewardpharmacyservicewithactiveimplementationoftherapeuticdrugmonitoringforvancomycinandteicoplaninanepidemiologicalsurveillancestudyusingjapaneselargehealthinsuranceclaimsdatabase
AT kashiwagihitoshi associationofthewardpharmacyservicewithactiveimplementationoftherapeuticdrugmonitoringforvancomycinandteicoplaninanepidemiologicalsurveillancestudyusingjapaneselargehealthinsuranceclaimsdatabase
AT miyaitakayuki associationofthewardpharmacyservicewithactiveimplementationoftherapeuticdrugmonitoringforvancomycinandteicoplaninanepidemiologicalsurveillancestudyusingjapaneselargehealthinsuranceclaimsdatabase
AT sugawaramitsuru associationofthewardpharmacyservicewithactiveimplementationoftherapeuticdrugmonitoringforvancomycinandteicoplaninanepidemiologicalsurveillancestudyusingjapaneselargehealthinsuranceclaimsdatabase
AT takekumayoh associationofthewardpharmacyservicewithactiveimplementationoftherapeuticdrugmonitoringforvancomycinandteicoplaninanepidemiologicalsurveillancestudyusingjapaneselargehealthinsuranceclaimsdatabase